Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients

JAMA - Journal of the American Medical Association - Tập 295 Số 7 - Trang 761 - 2006
F. Xavier Pi‐Sunyer1, Louis J. Aronne, Hassan M. Heshmati, Jeanne Devin, Julio Rosenstock, for the RIO-North America Study Group
1Obesity Research Center, St Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY 10025, USA.

Tóm tắt

Từ khóa


Tài liệu tham khảo